Cantel Medical Corp. (NYSE:CMN) declared a semiannual dividend on Monday, October 17th. Stockholders of record on Tuesday, January 17th will be paid a dividend of 0.07 per share on Tuesday, January 31st. This represents a dividend yield of 0.18%. The ex-dividend date is Thursday, January 12th. This is an increase from Cantel Medical Corp.’s previous semiannual dividend of $0.06.

Shares of Cantel Medical Corp. (NYSE:CMN) traded up 0.45% on Monday, hitting $75.90. The stock had a trading volume of 103,730 shares. The company has a market cap of $3.14 billion, a price-to-earnings ratio of 52.78 and a beta of 1.59. Cantel Medical Corp. has a 12-month low of $55.01 and a 12-month high of $81.63. The stock has a 50 day moving average price of $77.84 and a 200-day moving average price of $71.26.

Cantel Medical Corp. (NYSE:CMN) last released its earnings results on Thursday, September 29th. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.11. The firm earned $179 million during the quarter. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. The company’s revenue for the quarter was up 18.3% on a year-over-year basis. During the same quarter last year, the business posted $0.39 earnings per share. On average, equities analysts expect that Cantel Medical Corp. will post $1.98 earnings per share for the current year.

Dividend History for Cantel Medical Corp. (NYSE:CMN)

CMN has been the subject of a number of recent research reports. Needham & Company LLC initiated coverage on Cantel Medical Corp. in a report on Wednesday, August 24th. They issued a “hold” rating for the company. Benchmark Co. initiated coverage on Cantel Medical Corp. in a report on Monday, August 29th. They issued a “buy” rating and a $83.00 target price for the company.

In other Cantel Medical Corp. news, CAO Steven C. Anaya sold 5,500 shares of Cantel Medical Corp. stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $77.07, for a total transaction of $423,885.00. Following the completion of the sale, the chief accounting officer now directly owns 48,132 shares of the company’s stock, valued at approximately $3,709,533.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ann E. Berman sold 1,453 shares of Cantel Medical Corp. stock in a transaction dated Friday, September 30th. The stock was sold at an average price of $77.56, for a total value of $112,694.68. Following the sale, the director now directly owns 5,424 shares of the company’s stock, valued at $420,685.44. The disclosure for this sale can be found here. Company insiders own 15.30% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the company. King Luther Capital Management Corp increased its stake in shares of Cantel Medical Corp. by 1.7% in the second quarter. King Luther Capital Management Corp now owns 204,145 shares of the company’s stock worth $14,031,000 after buying an additional 3,385 shares during the period. American International Group Inc. increased its stake in shares of Cantel Medical Corp. by 1.5% in the second quarter. American International Group Inc. now owns 26,669 shares of the company’s stock worth $1,833,000 after buying an additional 400 shares during the period. OMERS ADMINISTRATION Corp acquired a new stake in shares of Cantel Medical Corp. during the second quarter worth about $1,388,000. Janney Montgomery Scott LLC increased its stake in shares of Cantel Medical Corp. by 81.7% in the second quarter. Janney Montgomery Scott LLC now owns 7,838 shares of the company’s stock worth $538,000 after buying an additional 3,524 shares during the period. Finally, AXA acquired a new stake in shares of Cantel Medical Corp. during the second quarter worth about $1,252,000. 81.61% of the stock is owned by institutional investors.

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

5 Day Chart for NYSE:CMN

Receive News & Stock Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related stocks with our FREE daily email newsletter.